drugset / Trial / NCT00560300

Regulation of Bone Formation in Renal Osteodystrophy

NCT00560300 ↗

RandomizedFactorialOpen-labelTreatment

Summary

To examine the effects of two types of active vitamin D (calcitriol and doxercalciferol) and two phosphate binders (sevelamer and calcium carbonate) on the bone disease and blood tests of children with kidney failure

Timeline

Start
2000-11
Primary completion
—
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject 1 alpha D2 Unknown — —
Subject 1,25 dihydroxy vitamin D3 Unknown — —
Subject Calcium carbonate Other / unclassified — —
Subject Sevelamer Other / unclassified — —

Indications